A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis
Kidong Kim, Sarah Kim, TaeJin Ahn, Hyojin Kim, So-Jin Shin, Chel Hun Choi, Sungmin Park, Yong-Beom Kim, Jae Hong No, Dong Hoon Suh · 2023
Read A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis by Kidong Kim, Sarah Kim, TaeJin Ahn, Hyojin Kim, So-Jin Shin, Chel Hun Choi, Sungmin Park, Yong-Beom Kim, Jae Hong No, Dong Hoon Suh (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10709939.txt.
Description
Kidong Kim and co-authors build a gene-based test to tell two uterine tumors apart in a 2023 study. Leiomyoma is benign, while leiomyosarcoma is a dangerous cancer, and telling them apart guides surgery. The team mined public gene activity data for normal tissue and cancer samples.
They picked genes that vary much more in the cancer and built a classifier on seventeen genes. Four model types were compared, and network analysis explored what the genes do. A fresh set of clinical samples tested the trained model. A reliable test could spare benign cases from harsh treatment and speed care for cancer.
Catalog record
| CREATOR | Kidong Kim, Sarah Kim, TaeJin Ahn, Hyojin Kim, So-Jin Shin, Chel Hun Choi, Sungmin Park, Yong-Beom Kim, Jae Hong No, Dong Hoon Suh |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |